Cargando…
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
We evaluated the effect of tailoring treatments based on predictions informed by tumor molecular profiles across a range of cancers, using data from Caris Life Sciences. These included breast carcinoma, colorectal adenocarcinoma, female genital tract malignancy, lung non-small cell lung cancer, neur...
Autores principales: | Carter, Philip, Alifrangis, Costi, Cereser, Biancastella, Chandrasinghe, Pramodh, Belluz, Lisa Del Bel, Herzog, Thomas, Levitan, Joel, Moderau, Nina, Schwartzberg, Lee, Tabassum, Neha, Wen, Jinrui, Krell, Jonathan, Stebbing, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823623/ https://www.ncbi.nlm.nih.gov/pubmed/29507702 http://dx.doi.org/10.18632/oncotarget.24258 |
Ejemplares similares
-
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
por: Carter, Philip, et al.
Publicado: (2018) -
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans
por: Carter, Philip, et al.
Publicado: (2018) -
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
por: Carter, Philip, et al.
Publicado: (2017) -
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
por: Carter, Philip, et al.
Publicado: (2018) -
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018)